Corrigendum to "Systematic combination screening reveals synergism between rapamycin and sutent against human lung cancer" [Cancer Letter 342(2014) 159-166]
Cancer Lett. 2020 Feb 1:470:220.
doi: 10.1016/j.canlet.2019.12.001.
Epub 2019 Dec 6.
1 Division of Anti-tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, PR China.
2 Division of Anti-tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, PR China. Electronic address: jding@simm.ac.cn.
3 Division of Anti-tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, PR China. Electronic address: lhmeng@simm.ac.cn.